Guangke Lenses in Congenital Cataract
Key facts
- Who runs it
- Eye & ENT Hospital of Fudan University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 6 Aug 2025
- Expected to end
- 6 Aug 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Conventional Bifocal Lenses
- Individually Customized Bifocal + Defocus Lenses
- Record updated
- 21 August 2026
Who can take part
- Age
- 4 years to 12 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Aged 4 to 12 years (inclusive) at the time of enrollment. Diagnosed with bilateral congenital cataracts. Has undergone bilateral cataract extraction with intraocular lens (IOL) implantation
- Time since cataract surgery is between 1 to 6 months (inclusive) at the time of enrollment
- Able to undergo regular ophthalmic examinations (including refraction, axial length measurement, and intraocular pressure assessment)
- Parent(s) or legal guardian(s) are willing and able to provide written informed consent
Who cannot take part
- Previous or current use of myopia control treatments, including but not limited to atropine eye drops, orthokeratology (Ortho-K) lenses, or other myopia control spectacle lenses
- Presence of any systemic disease (e.g., metabolic disorders, autoimmune diseases, genetic syndromes, etc.)
- Presence of any ocular disease other than congenital cataracts (e.g., glaucoma, uveitis, retinal disorders, corneal diseases, strabismus, amblyopia, etc.)
- History of ocular trauma or intraocular surgery other than cataract extraction and IOL implantation
- Known allergy or hypersensitivity to any materials or components used in the study lenses
- Inability to comply with the study protocol or complete scheduled follow-up visits
- Participation in another interventional clinical trial within the past 30 days
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Congenital cataract
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to investigate whether individually customized bifocal + defocus spectacles can slow myopic shift in children after congenital cataract surgery.
The 2 groups in the trial
- Active Comparator: Conventional Bifocal LensesExisting treatment, for comparison
Participants in this arm will wear conventional bifocal spectacles (without defocus design).
Treatment: Conventional Bifocal Lenses
- Experimental: Individually Customized Bifocal + Defocus LensesTreatment being tested
Participants in this arm will wear individually customized bifocal spectacles with peripheral defocus design.
Treatment: Individually Customized Bifocal + Defocus Lenses
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigation of Guangke Lenses' Efficacy in Delaying Myopia Onset/Progression in Postoperative Congenital Cataract Children
- Criteria questions
- Built from NCT07778797, who can take part
- Record updated
- 21 August 2026